Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
For the first time, we now have a randomised trial comparing active monitoring, surgery, and radiation therapy for the management of localised prostate cancer.
In a recent BJU International article, experts note that the investigators are to be congratulated on their highly anticipated landmark study, the Prostate testing for cancer and Treatment (ProtecT) trial; however, they point to several limitations in the recruitment of patients for the study and differences in the active monitoring protocol in the study compared with contemporary practice.
Considerable advances in treatment methods after the trial may also limit the results' relevance to current care.
"The utilisation of observational data continues to be important in current times," the authors wrote.
Source: Wiley
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.